Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FPHAX vs. QAAGZX: which is better?

Bottom line

FPHAX vs QAAGZX: the short answer

FPHAX (Pharmaceuticals Portfolio) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are quite different portfolios: only about 37% of their top holdings (by weight) are shared.

But QAAGZX is far broader, holding 277 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.

FPHAX is cheaper at 0.67% vs 0.86% — a difference of $19 a year per $10,000 invested.

Over five years, FPHAX returned +12.6% a year vs +4.1% for QAAGZX (reporting dates differ).

Updated Nov 19, 2026

FPHAX vs QAAGZX side by side

FPHAXQAAGZX
TypeMutual fundETF
Fund familyFidelityT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.67%0.86%
Annual cost per $10k$67$86
10-yr cost on $10k (prospectus)$835$1,061
Max front load—None
12b-1 fee0%0%
1-yr return+30.3%+18.1%
5-yr return (annualized)+12.6%+4.1%
10-yr return (annualized)+10.0%+9.0%
Best quarter+18.5%+23.4%
Worst quarter−13.6%−15.8%
Net assets (fund)$1.5B$751.7M
Number of holdings57277
Portfolio turnover77%65%
Returns as ofApr 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFPHAXQAAGZXDifference
2025+30.3%+18.1%+12.2%
2024+9.4%+1.7%+7.7%
2023+12.5%+3.0%+9.6%
2022+1.0%−12.5%+13.5%
2021+11.8%+13.1%−1.3%
2020+11.1%+29.6%−18.6%
2019+31.6%+29.0%+2.7%
2018+5.8%+1.1%+4.7%
2017+10.7%+27.6%−16.9%
2016−16.3%−10.5%−5.8%

Source: Fund prospectus bar charts

Holdings overlap

5 of FPHAX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingFPHAXQAAGZX
ELI LILLY and CO28.78%14.06%
MERCK and CO INC4.74%4.00%
Gilead Sciences Inc3.97%2.79%
JOHNSON and JOHNSON3.77%6.64%
Moderna Inc1.57%0.83%

Source: SEC Form N-PORT

FPHAX top 10

  1. ELI LILLY and CO — 28.78%
  2. Gsk Plc — 8.17%
  3. Viatris Inc — 5.45%
  4. Ucb Sa — 5.09%
  5. MERCK and CO INC — 4.74%
  6. Roche Holding Ag — 4.54%
  7. Legend Biotech Corp — 4.53%
  8. Astrazeneca Plc — 4.22%
  9. Elanco Animal Health Inc — 4.15%
  10. Jazz Pharmaceuticals Plc — 4.09%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between FPHAX and QAAGZX?
FPHAX (Pharmaceuticals Portfolio) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are quite different portfolios: only about 37% of their top holdings (by weight) are shared. But QAAGZX is far broader, holding 277 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
Which is cheaper, FPHAX or QAAGZX?
FPHAX has the lower expense ratio (0.67%).
Should I own both FPHAX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.